| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| ccx-168 | c5a anaphylatoxin chemotactic receptor | NA | Clinical trial target | TTD , DGIDB | Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Granulomatosis with polyangiitis[MeSHID:D014890] Anemia Hemolytic Congenital[MeSHID:D000745] Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis[MeSHID:D056648] eosinophil[MeSHID:D004804] Eosinophilia[MeSHID:D004802] |
63.65 | phase 3 | unknown |
| click here to return to the previous page | ||||||||